Enable investigators to apply earlier in their independent research careers, allowing them to secure grant funding that will launch and sustain productive research careers. To what extent do the efforts described in the Plan for Enhancing Diverse Perspectives further the significance of the project? Please note: These dates are not applicable to administrative supplements solicited through NOSIs.Supplement to Advance Research (STAR) The NIGMS Maximizing Investigators' Research Award (MIRA) provides support for the NIGMS-relevant program of research in an investigator's laboratory. U.S. citizenship or permanent resident status is required.Duration: Up to 6 yearsCommitment: Full-time research fellowshipProvisions:NRSA Stipends, Tuition/Fees, and Institutional AllowanceApplications Due: Standard dates, Predoctoral Individual National Research Service Award, To provide predoctoral support of research leading to the Ph.D. or equivalent research degree for individuals to extend their potential for a career in research in arthritis, muscle, bone, musculoskeletal, and/or skin diseases. The BTOD award can only provide support in a MIRA PD/PI's laboratory for late-stage technology development and dissemination efforts. Applications will compete for available funds with all other recommended applications. For a complete list of NIH grants that do not disqualify a PD/PI from being considered a New Investigator, see the NIH Definition of New Investigator. NIH no longer has a program for rapid turnaround for NI applications. This may include development of technical expertise and administrative skills such as mentoring. Applications from investigators who are not eligible to receive the award will be administratively withdrawn without review. The Limited Competition: Small Grant Program for NIAMS K01, K08, K23, and K25 Recipients (R03) is intended to enhance the capability of NIAMS-supported K awardees to conduct research as they complete their transition to fully independent investigator status.Duration: No more than 2 years, not renewable.Budget Cap: Multi-year funds up to $100,000 direct costs for entire project periodApplication Due Dates: June 20, 2022; October 19, 2022; February 21, 2023; June 19, 2023; October 19, 2023; February 20, 2024; June 19, 2024; October 21, 2024; February 19, 2025. Plan to enhance recruiting of women and individuals from groups traditionally under-represented in the biomedical, behavioral, and clinical research workforce. Did you find the content you were looking for? The goal of MIRA is to increase the efficiency and efficacy of NIGMS funding. Following initial peer review, recommended applications will receive a second level of review by the National Advisory General Medical Sciences Council. If equipment is requested in Section C, do not add the equipment budget in Section F. If subaward/consortium costs are requested, the subaward/consortium direct costs (not including consortium F&A) should be included in the "Requested Direct Costs. Staff & Contact Information - Office of State Inspector General Subscriptions These are agreements between NIH and the award recipient in which the NIH acts as the partner in the research effort for projects similar to grants. Individual awards are based on the application submitted to, and as approved by, the NIH and are subject to the IC-specific terms and conditions identified in the NoA. Letters from former mentors are not required, nor encouraged, except in the case of continuing collaborations. NHGRI Program Contact: Lisa Chadwick RFA-HG-21-041 : New Investigators to Promote Workforce Diversity in Genomics, Bioinformatics or Bioengineering and Biomedical Imaging Research (R01, Clinical Trial Optional) Next Application Due Date: February 22, 2023 NHGRI Program Contact: Jyoti Dayal The NIAMS will only consider requests for administrative supplements to provide support for the accomplishment of the original aims of a project in circumstances in which these unanticipated costs have arisen, placing the overall success of the project in question. See FOA for guidelines:Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed) This site is protected by reCAPTCHA and the GooglePrivacy Policyand Terms of Serviceapply. Applications will be evaluated for scientific and technical merit by (an) appropriate Scientific Review Group(s) convened by Center for Scientific Review, in accordance with NIH peer review policy and procedures, using the stated review criteria. Early-Stage Investigator Eligibility | National Institute of In carrying out stewardship of grant programs, NIGMS will periodically evaluate the MIRA program, employing the representative measures identified below. For support to develop and/or implement a program as it relates to a category in one or more of the areas of education, information, training, technical assistance, coordination, or evaluation. Should the applicant organization successfully compete for an award, recipients of federal financial assistance (FFA) from HHS will be required to complete an HHS Assurance of Compliance form (HHS 690) in which the recipient agrees, as a term and condition of receiving the grant, to administer their programs in compliance with federal civil rights laws that prohibit discrimination on the basis of race, color, national origin, age, sex and disability, and agreeing to comply with federal conscience laws, where applicable. Reviewers will assess the information provided in this section of the application, including 1) the Select Agent(s) to be used in the proposed research, 2) the registration status of all entities where Select Agent(s) will be used, 3) the procedures that will be used to monitor possession use and transfer of Select Agent(s), and 4) plans for appropriate biosafety, biocontainment, and security of the Select Agent(s). Reviewers will provide an overall impact score to reflect their assessment of the likelihood for the research program to exert a sustained, powerful influence on the research field(s) involved, in consideration of the following review criteria and additional review criteria (as applicable for the program proposed). New investigators are encouraged to apply for an R01 (see NOT-OD-09-013, "Revised New and Early Stage Investigator Policies) or an R03 (see NIAMS Small Grant Program for New Investigators). For additional guidance regarding how the provisions apply to NIH grant programs, please contact the Scientific/Research Contact that is identified in Section VII under Agency Contacts of this NOFO. Fellowships to provide opportunities for experienced scientists to make major changes in the direction of research careers, to broaden scientific background, and to acquire new research capabilities regarding arthritis, muscle, bone, musculoskeletal, and/or skin diseases. For Early Stage Investigator MIRA applications it is okay to have a similar ReWARD application under review at the same time, but only one application will be funded. and Other Dual Doctoral Degree Individual National Research Service Award, To provide predoctoral support for individual M.D./Ph.D. NIH NOFOs outline intended research goals and objectives. All registrations must be completed prior to the application being submitted. Study Record: PHS Human Subjects and Clinical Trials Information. SF424(R&R) Project/Performance Site Locations. Note: Delayed onset does NOT apply to a study that can be described but will not start immediately (i.e., delayed start). The committee will evaluate the involvement of live vertebrate animals as part of the scientific assessment according to the following criteria: (1) description of proposed procedures involving animals, including species, strains, ages, sex, and total number to be used; (2) justifications for the use of animals versus alternative models and for the appropriateness of the species proposed; (3) interventions to minimize discomfort, distress, pain and injury; and (4) justification for euthanasia method if NOT consistent with the AVMA Guidelines for the Euthanasia of Animals. For Established Investigator or New Investigator MIRA applications, it is NOT okay to have similar ReWARD application under review at the same time. Larger award amount than the current average NIGMS R01 award to ESIs. Project-based opportunities to enhance the research environment to benefit early- and mid-career investigators. In FY 2009, NIH announced a new policy involving the identification of early stage investigators (ESIs). The latest news and policy updates from CSR. The supplement may be used to support additional personnel, computational services, supplies, and equipment that will promote the continuity of the career development research project during a period in which the PD/PI experiences critical life evens which have the potential to impact research progress or potential productivity. National Institute of Environmental Health Sciences Office of the Director, NIH Notice of NHGRI Participation in PAR-22-181, "Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional) (NOT-HG-23-040) National Human Genome Research Institute This attachment should be titled Plan for Enhancing Diverse Perspectives.. April Hearron. 5. This grant supports the administrative planning and development of a clinical trial implementation cooperative agreement (U01). Participation of individuals from diverse backgrounds, including groups traditionally underrepresented in the biomedical, behavioral, and clinical research workforce (see. Once the multiple PI application is funded, you lose your ESIstatus. At least 6 months of support must be remaining on the grant at the start of the supplement award. Other supplements offered by NIGMS may also be made available to MIRA recipients, depending on the intention and constraints of the particular supplement program.". If your status isn't correct, contact the, Once you apply for and receive certain NIH awards, you no longer qualify as anESI. Am I still eligible if I'm an Early Stage Investigator but have an R01 application pending? Program Directors/Principal Investigators (PD(s)/PI(s)). See the NIH Grants Policy Statement for additional information on this reporting requirement. It is critical that applicants follow the instructions in the Research (R) Instructions in theSF424 (R&R) Application Guideexcept where instructed in this notice of funding opportunity to do otherwise. Provide a rationale for the changes in the context of the originally proposed research program and explain how the research continues to fit within NIGMS mission interests. Definition and other information provided under the R13 Guidelines related links. Instead, a total requested direct cost amount for each budget period, including requests for equipment purchase, is required. Refer to NIH's Early Stage Investigator policies for information about what awards impact ESI status. is acting as the primary caregiver for an ailing spouse, child, partner or a member of the immediate family. PDs/PIs who submitted a MIRA application in previous years and are still eligible for this NOFO (i.e., retain their ESI status) are welcome to apply, but must submit a New application because Resubmission applications are not allowed. ClinicalTrials.gov: If an award provides for one or more clinical trials. For further information on the PEDP, please see https://braininitiative.nih.gov/about/pedp-key-elements-and-examples. These awards are generally reserved for individuals interested in switching to a new research field, for individuals who have interrupted their career because of illness or pressing family care responsibilities, or for faculty at minority institutions who wish to enhance their capacity for independent research.Duration: Up to 5 yearsProvisions: Support is provided for salary up to $75,000 for a minimum 75% effort, fringe benefits, and other research expenses up to $20,000.Applications Due: Standard dates, Mentored Clinical Scientist Development Investigator Awards, To support supervised study and research for individuals with clinical doctoral degrees who have the potential to develop into productive, clinical investigators.Duration: 3 to 5 yearsProvisions: Support is provided for salary up to $100,000 for a minimum 75% effort (with the exception of orthopaedic surgeons, who may devote a minimum of 50% effort*), fringe benefits, and other research expenses up to $30,000.Applications Due: Standard dates*Please see NOT-AR-16-012, Mentored Patient-Oriented Research Career Development Award, To support supervised study and research for individuals with clinical doctoral degrees who have the potential to develop into productive, clinical investigators focusing on patient-oriented research. The NIAMS funds the following types of grants: Research Grants Research Project Grants (R) Research Programs and Centers (P) Research-Related Programs (S) Supplement Programs Training and Career Development Grants Fellowship Programs (F) Increase flexibility for investigators to adapt to important new research directions as opportunities arise, rather than being bound to specific aims proposed in advance of the studies.